Importantly, in an AR-overexpressing TNBC cell line (MDA-MB-231-AR), SARMs (enobosarm and GTx-027), but not the AR antagonist bicalutamide, reduced cell proliferation and inhibited the in vivo tumor growth of MDA-MB-231-AR xenografts [93]. This evidence concerns the gene AR and neoplasm.